U.S. pharmaceutical giant Pfizer Inc. on Friday requested Japan's health ministry to approve its novel coronavirus vaccine, making it the first drugmaker to file such a request in the country.If approved, vaccinations could begin in Japan as early as March, government officials said. Japan has already agreed with Pfizer to receive a supply of 120 million doses in the first half of next year, enough for 60 million people, or roughly half of the population."We will strictly screen the effectiveness and safety (of the vaccine) before making a judgment," health minister Norihisa Tamura told a n…READ FULL ARTICLE
